Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Revenue in billion Japanese yen |
|---|---|
| 2023 | 921.86 |
| 2022 | 820.21 |
| 2021 | 703.3 |
| 2020 | 613.84 |
| 2019 | 628.9 |
| 2018 | 599.48 |
| 2017* | 587.78 |
| 2016 | 514.16 |
| 2015 | 525.03 |
| 2014 | 489.51 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
May 2025
More information
Region
Japan
Survey time period
fiscal years 2013 to 2024; company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
Special properties
consolidated data
Supplementary notes
*From fiscal year 2017 onwards, the company adopted the International Financial Reporting Standards (IFRS). This is reflected in the reported values for fiscal year 2016.
Figures prior to fiscal year 2021 come from previous reporting.
100 Japanese yen equal 0.69 U.S. dollars or 0.61 euros as of May 2025.
Figures have been rounded.
Citation formats
